CC BY 4.0 · Rev Bras Ginecol Obstet 2020; 42(06): 305-309
DOI: 10.1055/s-0040-1713795
Editorial
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

COVID-19 and Assisted Reproduction: A Point of View on the Brazilian Scenario

1   Hospital Sírio-Libanês, Brasília, DF, Brazil
,
2   Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
,
2   Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
,
2   Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
,
2   Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
› Author Affiliations
Further Information

Publication History

Publication Date:
30 June 2020 (online)

The Epidemic of COVID-19 in Brazil and Worldwide

The world is experiencing a pandemic with no recent similar events, caused by the new coronavirus (SARS-CoV-2). Since December 31, 2019, when the World Health Organization (WHO) was informed about the first cases of pneumonia in the city of Wuhan, Hubei province, China,[1] the disease (COVID-19) spread rapidly through the whole planet. According to the WHO, on May 24, 2020, the world had already confirmed 5,204,508 COVID-19 cases, with a total of 337,687 deaths.[2] In Brazil, on that date, the Ministry of Health had already registered more 363,211 confirmed cases and 22,666 deaths.[3]

Indeed, the WHO warns of the need for caution in interpreting available data, since the sources of information are diverse, as well as the inclusion criteria and other variables may diverge, ultimately resulting in eventual underestimations of the numbers of cases and deaths in each country.[2] However, based on observations from previous epidemics caused by other respiratory viruses, and using specific indicators to measure the transmissibility of the new coronavirus and the clinical severity of COVID-19, preliminary data released in China appear to be sufficient to place the current pandemic on the scale of major epidemics recorded in history, comparable only to the 1918 influenza pandemic, also known as the Spanish flu pandemic.[4]

In order to predict an epidemiological behavior to the COVID-19 pandemic, mathematical projections appear as a forecasting tool, far from perfect, but viable and perfectly acceptable in a time of uncertainty. It is understood that the projections allow authorities and health services to prepare initial action plans, with due attention being paid to frequent monitoring, given the potentially mutable dynamics of SARS-CoV-2 and the rapid change of scenarios. Of note, such characteristics hinder the extrapolation of information from one country to another.

According to the Institute for Health Metrics and Evaluation (IHME), the curve of the epidemic in Brazil is on a plateau and the country will have more than 190 thousand new infections daily by SARS-CoV-2 between May 14 and June 21, 2020. Consequently, it is estimated that we will have at least 800 deaths per day by COVID-19 between May 23 and July 30, 2020. Undeniably, the projection of that institute draws attention to the total number of deaths from the disease in the country, estimated to be of 88,305 until August 4, 2020, varying from about 33 thousand in the best scenario to more than 190 thousand lost lives in the worst perspective. That is an estimative greater than the sum of projected deaths for Italy and Spain together, which is to be expected, once the number of intensive care beds demanded (more than 8 thousand) already exceeds the number of beds offered in the country for treatment of COVID-19 (about 4 thousand).[5]

 
  • References

  • 1 World Health Organization. Pneumonia of unknown cause – China [Internet]. 2020 [cited 2020 May 19]. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/
  • 2 World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 125 [Internet]. 2020 [cited 2020 May 25]. Available from: https://apps.who.int/iris/bitstream/handle/10665/332230/nCoVsitrep24May2020-eng.pdf?sequence=1&isAllowed=y
  • 3 Ministério da Saúde. Covid 19: Painel Coronavírus [Internet]. 2020 [cited 2020 May 25]. Available from: https://covid.saude.gov.br
  • 4 Freitas ARR, Napimoga M, Donalisio MR. Assessing the severity of COVID-19. Epidemiol Serv Saude 2020; 29 (02) e2020119 . Doi: 10.5123/s1679-49742020000200008
  • 5 Institute for Health Metrics and Evaluation. COVID-19 Projections: Brazil [Internet]. 2020 [cited 2020 May 22]. Available from: https://covid19.healthdata.org/brazil
  • 6 World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations [Internet]. 2020 [cited 2020 May 19]. Available from: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations
  • 7 Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): social distancing [Internet]. 2020 [cited 2020 May 19]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/social-distancing.html
  • 8 Lu J, Gu J, Li K, Xu C, Su W, Lai Z. , et al. COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020. Emerg Infect Dis 2020; 26 (07) DOI: 10.3201/eid2607.200764. [ahead of print]
  • 9 Park SY, Kim YM, Yi S, Lee S, Na BJ, Kim CB. , et al. Coronavirus disease outbreak in call center, South Korea. Emerg Infect Dis 2020; 26 (08) DOI: 10.3201/eid2608.201274. [ahead of print]
  • 10 Ghinai I, Woods S, Ritger KA, McPherson TD, Black SR, Sparrow L. , et al. Community transmission of SARS-CoV-2 at two family gatherings – Chicago, Illinois, February-March 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (15) 446-450 . Doi: 10.15585/mmwr.mm6915e1
  • 11 Koo JR, Cook AR, Park M, Sun Y, Sun H, Lim JT. , et al. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis 2020; 20 (06) 678-688 . Doi: 10.1016/S1473-3099(20)30162-6
  • 12 Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N. , et al; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health 2020; 5 (05) e261-e270 . Doi: 10.1016/S2468-2667(20)30073-6
  • 13 Jarvis CI, Van Zandvoort K, Gimma A, Prem K. ; CMMID COVID-19 working group, Klepac P, et al; CMMID COVID-19 working group. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med 2020; 18 (01) 124 . Doi: 10.1186/s12916-020-01597-8
  • 14 World Health Organization. Coronavirus disease 2019: strategy and planning [Internet]. 2020 [cited 2020 May 19]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/strategies-and-plans
  • 15 Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC. , et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191 (01) 292-297 . Doi: 10.1016/j.ajog.2003.11.019
  • 16 Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol Infect 2019; 52 (03) 501-503 . Doi: 10.1016/j.jmii.2018.04.005
  • 17 Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W. , et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815 . Doi: 10.1016/S0140-6736(20)30360-3
  • 18 Liu D, Li L, Wu X, Zheng D, Wang J, Yang L. , et al. Pregnancy and perinatal outcomes of women with Coronavirus Disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 2020; •••: 1-6 . Doi: 10.2214/AJR.20.23072. [ahead of print]
  • 19 Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X. , et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis 2020; 20 (05) 559-564 . Doi: 10.1016/S1473-3099(20)30176-6
  • 20 Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020; ••• DOI: 10.5858/arpa.2020-0901-SA. [ahead of print]
  • 21 Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020; 222 (05) 415-426 . Doi: 10.1016/j.ajog.2020.02.017
  • 22 Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M. , et al. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020; 2 (02) 100107 . Doi: 10.1016/j.ajogmf.2020.100107
  • 23 Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G. , et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9 (01) 51-60 . Doi: 10.21037/tp.2020.02.06
  • 24 Algarroba GN, Rekawek P, Vahanian SA, Khullar P, Palaia T, Peltier MR. , et al. Visualization of SARS-CoV-2 virus invading the human placenta using electron microscopy. Am J Obstet Gynecol 2020; ••• DOI: 10.1016/j.ajog.2020.05.023. [ahead of print]
  • 25 Penfield CA, Brubaker SG, Limaye MA, Lighter J, Ratner AJ, Thomas KM. , et al. Detection of SARS-COV-2 in placental and fetal membrane samples. Am J Obstet Gynecol MFM 2020; 100133: 100133 . Doi: 10.1016/j.ajogmf.2020.100133. [ahead of print]
  • 26 Baud D, Greub G, Favre G, Gengler C, Jaton K, Dubruc E. , et al. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection. JAMA 2020; 323 (21) 2198-2200 . Doi: 10.1001/jama.2020.7233
  • 27 Hosier H, Farhadian S, Morotti R, Deshmukh U, Lu-Culligan A, Campbell K. , et al. SARS-CoV-2 infection of the placenta. medRxiv [Preprint] 2020; DOI: 10.1101/2020.04.30.20083907.
  • 28 Vivanti A, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Cao JD. , et al. Transplacental transmission of SARS-CoV-2 infection. Res Squ 2020; . Preprint DOI: 10.21203/rs.3.rs-28884/v1.
  • 29 Chen D, Yang H, Cao Y, Cheng W, Duan T, Fan C. , et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynaecol Obstet 2020; 149 (02) 130-136 . Doi: 10.1002/ijgo.13146
  • 30 Ministério da Saúde. Agência Nacional de Vigilância Sanitária (ANVISA). Nota Técnica no. 23/2020/SEI/GSTCO/DIRE1/ANVISA [Internet]. Diretrizes para a realização de procedimentos de Reprodução Humana Assistida face a pandemia de coronavírus (SARS-CoV-2). 2020 [cited 2020 May 19]. Available from: https://www.sbrh.org.br/wp-content/uploads/2020/05/Nota-Técnica-Anvisa-RHA-e-Covid.pdf
  • 31 Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005; 353 (01) 64-73 . Doi: 10.1056/NEJMra043475
  • 32 Heffner LJ. Advanced maternal age–how old is too old?. N Engl J Med 2004; 351 (19) 1927-1929 . Doi: 10.1056/NEJMp048087
  • 33 Habbema JD, Eijkemans MJ, Leridon H, te Velde ER. Realizing a desired family size: when should couples start?. Hum Reprod 2015; 30 (09) 2215-2221 . Doi: 10.1093/humrep/dev148
  • 34 Eijkemans MJC, Kersten FAM, Lintsen AME, Hunault CC, Bouwmans CAM, Hakkaart-van Roijen L. , et al. Cost-effectiveness of ‘immediate IVF’ versus ‘delayed IVF’: a prospective study. Hum Reprod 2017; 32 (05) 999-1008 . Doi: 10.1093/humrep/dex018
  • 35 Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J. , et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203 (02) 622-630 . Doi: 10.1002/path.1560
  • 36 Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with Coronavirus Disease 2019. JAMA Netw Open 2020; 3 (05) e208292 . Doi: 10.1001/jamanetworkopen.2020.8292
  • 37 Paoli D, Pallotti F, Colangelo S, Basilico F, Mazzuti L, Turriziani O. , et al. Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab. J Endocrinol Invest 2020; 1-4 DOI: 10.1007/s40618-020-01261-1. [ahead of print.]
  • 38 Pan F, Xiao X, Guo J, Song Y, Li H, Patel DP. , et al. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril 2020; 113 (06) 1135-1139 . Doi: 10.1016/j.fertnstert.2020.04.024
  • 39 Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease (COVID-19) and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril 2020; ••• DOI: 10.1016/j.fertnstert.2020.05.001. [ahead of print]
  • 40 Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G. , et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod 2020; May 4; gaaa030 . Doi: 10.1093/molehr/gaaa030. [ahead of print].
  • 41 Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity 2020; 52 (05) 737-741 . Doi: 10.1016/j.immuni.2020.04.012
  • 42 American Society for Reproductive Medicine. Patient management and clinical recommendations during the Coronavirus (COVID-19) pandemic [Internet]. 2020 [cited 2020 May 19]. Available from: https://www.asrm.org/news-and-publications/covid-19/statements/patient-management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic/